Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Optimising Renal Outcome in Myeloma Renal Failure
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block
- Status
- COMPLETED
- Phase
- NA
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting Only
- Status
- COMPLETED
- Phase
- PHASE1
Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Pre-Emptive Analgesia in Ano-Rectal Surgery
- Status
- COMPLETED
- Phase
- NA